Table of Contents
Hepatitis Research and Treatment
Volume 2010, Article ID 537827, 5 pages
http://dx.doi.org/10.1155/2010/537827
Clinical Study

Retreatment of Patients Nonresponsive to Pegylated Interferon and Ribavirin with Daily High-Dose Consensus Interferon

1Division of Digestive Diseases, Beth Israel Medical Center and Albert Einstein, College of Medicine, New York, NY 10003, USA
2Division of Gastroenterology, New York University Medical Center, New York, NY 10016, USA
3Division of Liver Diseases, Mount Sinai School of Medicine, New York, NY 10029, USA
4Division of Gastroenterology, Hepatology and Nutrition, North Shore University Hospital, Manhasset, NY 11030, USA

Received 17 April 2010; Revised 21 July 2010; Accepted 4 August 2010

Academic Editor: Tatehiro Kagawa

Copyright © 2010 Douglas F. Meyer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. J. Hadziyannis, H. Sette Jr., T. R. Morgan et al., “Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose,” Annals of Internal Medicine, vol. 140, no. 5, pp. 346–355, 2004. View at Google Scholar · View at Scopus
  2. J. G. McHutchison, E. J. Lawitz, M. L. Shiffman et al., “Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection,” New England Journal of Medicine, vol. 361, no. 6, pp. 580–593, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. M. G. Ghany, D. B. Strader, D. L. Thomas, and L. B. Seeff, “Diagnosis, management, and treatment of hepatitis C: an update,” Hepatology, vol. 49, no. 4, pp. 1335–1374, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. E. J. Heathcote, E. B. Keeffe, S. S. Lee et al., “Re-treatment of chronic hepatitis C with consensus interferon,” Hepatology, vol. 27, no. 4, pp. 1136–1143, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. E. B. Melian and G. L. Plosker, “Interferon alfacon-1: a review of its pharmacology and therapeutic efficacy in the treatment of chronic hepatitis C,” Drugs, vol. 61, no. 11, pp. 1661–1691, 2001. View at Google Scholar · View at Scopus
  6. S. Kaiser, H. Hass, M. Gregor et al., “Successful retreatment of chronic hepatitis C patients with a using daily consensus interferon and ribavirin,” Hepatology, vol. 40, no. 4, article 240A, 2004. View at Google Scholar
  7. C. B. Leevy, “Consensus interferon and ribavirin in patients with chronic hepatitis C who were nonresponders to pegylated interferon alfa-2b and ribavirin,” Digestive Diseases and Sciences, vol. 53, no. 7, pp. 1961–1966, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Cornberg, J. Hadem, E. Herrmann et al., “Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: a randomized open-label pilot study,” Journal of Hepatology, vol. 44, no. 2, pp. 291–301, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. B. R. Bacon, M. L. Shiffman, F. Mendes et al., “Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results,” Hepatology, vol. 49, no. 6, pp. 1838–1846, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. N. D. Theise, “Liver biopsy assessment in chronic viral hepatitis: a personal, practical approach,” Modern Pathology, vol. 20, no. 1, pp. S3–S14, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. M. H. Sjogren, R. Sjogren, K. Holtzmuller et al., “Interferon alfacon-1 and ribavirin versus interferon α-2b and ribavirin in the treatment of chronic hepatitis C,” Digestive Diseases and Sciences, vol. 50, no. 4, pp. 727–732, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. W. O. Böcher, M. Schuchmann, R. Link et al., “Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-α therapy,” Liver International, vol. 26, no. 3, pp. 319–325, 2006. View at Publisher · View at Google Scholar · View at Scopus